CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity

Breast Cancer Research

Volumn 14, Issue 3, 2012, Pages

  Montgomery, Nicola ^a   Hill, Ashleigh ^a   McFarlane, Suzanne ^a   Neisen, Jessica ^a   O'Grady, Anthony ^b   Conlon, Susie ^b   Jirstrom, Karin ^c   Kay, Elaine W ^b   Waugh, David J J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BEAUMONT HOSPITAL   (Ireland)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; CATHEPSIN K; CELL SURFACE RECEPTOR; COLLAGEN; HYALURONIC ACID; HYALURONIC ACID RECEPTOR CD44; MATRIGEL; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PLASMINOGEN ACTIVATOR INHIBITOR; SERINE PROTEINASE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR; HERMES ANTIGEN; MATRIX METALLOPROTEINASE 14; SMALL INTERFERING RNA;

ARTICLE; BASAL LIKE BREAST CANCER; BASEMENT MEMBRANE; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CANCER TISSUE; CELL INVASION; COLLAGEN DEGRADATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; ENZYME INHIBITION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; BASAL CELL CARCINOMA; BREAST TUMOR; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; TUMOR CELL LINE; UPREGULATION;

ANTIGENS, CD44; BREAST NEOPLASMS; CATHEPSIN K; CELL LINE, TUMOR; COLLAGEN; FEMALE; HUMANS; HYALURONIC ACID; MATRIX METALLOPROTEINASE 14; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS, BASAL CELL; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RNA INTERFERENCE; RNA, SMALL INTERFERING; SERINE PROTEASES; SIGNAL TRANSDUCTION; UP-REGULATION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84861337133     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3199     Document Type: Article

References (37)

1. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rjin M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lonning PE, Borresen-Dale A. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874. 10.1073/pnas.191367098, 58566, 11553815.
2. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massagué R. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524. 10.1038/nature03799, 1283098, 16049480.
3. Gotte M, Yip GW. Heparanase, hyaluronan and CD44 in cancers: a breast carcinoma perspective. Cancer Res 2006, 66:10233-10237. 10.1158/0008-5472.CAN-06-1464, 17079438.
4. Auvinen P, Tammi R, Parkinnen J, Tammi M, Agren U, Johansson R, Hirvikoski P, Eskelinen M, Kosma VM. Hylauronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 2000, 156:529-536. 10.1016/S0002-9440(10)64757-8, 1850058, 10666382.
5. Karihtala P, Soini Y, Auvinen P, Tammi R, Tammi M, Kosma VM. Hyaluronan and breast cancer. J Histochem Cytochem 2007, 55:1191-1198. 10.1369/jhc.7A7270.2007, 17827165.
6. Klingbeil P, Natrajan R, Everitt G, Vatcheva R, Marchio C, Palacios J, Buerger H, Reis-Filho JS, Isacke CM. CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification. Breast Cancer Res Treat 2010, 120:95-109. 10.1007/s10549-009-0380-7, 19350388.
7. Hill A, McFarlane S, Mulligan K, Gillespie H, Draffin JE, Trimble A, Outhit A, Johnston PG, Harkin DP, McCormick D, Waugh DJJ. Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells. Oncogene 2006, 25:6079-6091. 10.1038/sj.onc.1209628, 16652145.
8. Ouhtit A, Abd Elmageed ZY, Abdraboh ME, Lioe TF, Raj MH. vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver. Am J Pathol 2007, 171:2033-2039. 10.2353/ajpath.2007.070535, 2111125, 17991717.
9. Balic M, Lin H, Young L, Hawes D, Giuliano A, McNamara G, Datar RH, Cote RJ. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 2006, 12:5615-5621. 10.1158/1078-0432.CCR-06-0169, 17020963.
10. Abraham BK, Fritz P, McClellan M, Hauptvogel P, Athelogou M, Brauch H. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 2005, 11:1154-1159.
11. Yu Q, Stamenkovic I. Localization of matrix metalloproteinase-9 to the cell surface provides a mechanism for CD44-promoted tumor invasion. Genes Dev 1999, 13:35-48. 10.1101/gad.13.1.35, 316376, 9887098.
12. Yu WH, Woessner JF, McNeish JD, Stamenkovic I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 2002, 16:307-323. 10.1101/gad.925702, 155329, 11825873.
13. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Seiki M. Membrane-type 1 metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 2001, 153:893-904. 10.1083/jcb.153.5.893, 2174329, 11381077.
14. Ueda J, Kajita M, Suenaga N, Fujii K, Seiki M. Sequence specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors. Oncogene 2003, 22:8716-8722. 10.1038/sj.onc.1206962, 14647466.
15. Duffy MJ, O'Grady P, Devaney D, O'Siorain L, Fennelly JJ, Lijnen HJ. Urokinase-plasminogen activator, a marker for aggressive breast carcinomas: preliminary report. Cancer 1988, 62:531-533. 10.1002/1097-0142(19880801)62:3<531::AID-CNCR2820620315>3.0.CO;2-B, 3134120.
16. Shimizu M, Cohen B, Golvasser P, Berman H, Virtanen C, Reedijk M. Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancer. Cancer Res 2011, 71:277-286. 10.1158/0008-5472.CAN-10-2523, 21199807.
17. Molerstrom E, Kovacs A, Lovgren K, Nemes S, Delle U, Danielsson A, Parris T, Brennan DJ, Jirstrom K, Karlsson P, Helou K. Upregulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer as detected by immunohistochemistry using tissue microarray. BMC Cancer 2010, 10:296-306. 10.1186/1471-2407-10-296, 2902444, 20553615.
18. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW. A collection of breast cancer cell lines for the study of distinct cancer subtypes. Cancer Cell 2006, 10:515-527. 10.1016/j.ccr.2006.10.008, 2730521, 17157791.
19. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R. A bone seeking clone exhibits different biological properties from the parental MDA-MB-231 human breast cancer cells and a brain seeking clone in vivo and in vitro. J Bone Miner Res 2001, 16:1486-1495. 10.1359/jbmr.2001.16.8.1486, 11499871.
20. Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJJ. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res 2004, 64:5702-5711. 10.1158/0008-5472.CAN-04-0389, 15313910.
21. Maxwell PJ, Gallagher R, Seaton A, Wilson C, Scullin P, Pettigrew J, Stratford IJ, Williams KJ, Johnston PG, Waugh DJJ. HIF-1 and NF-B-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells. Oncogene 2007, 26:7333-7345. 10.1038/sj.onc.1210536, 17533374.
22. Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, Larsimont D, Macgrogan G, Bergh J, Cameron D, Goldstein D, Duss S, Nicoulaz AL, Brisken C, Fiche M, Delorenzi M, Iggo R. Identification of molecular apocrine breast tumors by microarray analysis. Oncogene 2005, 7:4660-4671.
23. Madsen MA, Deryugina EI, Niessen S, Cravatt BF, Quigley JP. Activity-based protein profiling implicates urokinase activation as a key step in human fibrosarcoma intravasation. J Biol Chem 2006, 281:15997-16005. 10.1074/jbc.M601223200, 16611636.
24. Conn EM, Botkjaer KA, Kupriyanova TA, Andreasen PA, Deryugina EI, Quigley JP. Comparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasion. Am J Pathol 2009, 175:1638-1642. 10.2353/ajpath.2009.090384, 2751560, 19729488.
25. Conn EM, Madsen MA, Cravatt BF, Ruf W, Deryugina EI, Quigley JP. Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation. J Biol Chem 2008, 283:26518-26528. 10.1074/jbc.M803337200, 2546538, 18658134.
26. Sabeh F, Ota I, Holmbeck K, Birkedal-Hansen H, Soloway P, Balbin M, Lopez-Otin C, Shapiro S, Inada M, Krane S, Allen E, Chung D, Weiss SJ. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol 2004, 167:769-781. 10.1083/jcb.200408028, 2172570, 15557125.
27. Ishikawa T, Kamiyama M, Tani-Ishii N, Suzuki H, Ichikawa Y, Hamaguchi Y, Momiyama N, Shimada H. Inhibition of osteoclast differentiation and bone resorption by cathepsin K antisense oligonucleotides. Mol Carcinogen 2001, 32:84-91.
28. Ohno S, Im HJ, Knudson CB, Knudson W. Hyaluronan oligosaccharides induce matrix metalloproteinase 13 via transcriptional activation of NFkappaB and p38 MAPK in articular chondrocytes. J Biol Chem 2006, 281:17952-17960. 10.1074/jbc.M602750200, 3139229, 16648633.
29. Matsumoto M, Kogawa M, Wada S, Takayanagi H, Tsujimoto M, Katayma S, Hisatake K, Nogi Y. Essential role of p38 mitogen activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J Biol Chem 2004, 279:45969-45979. 10.1074/jbc.M408795200, 15304486.
30. Bourguignon LY, Gunja-Smith Z, Iida N, Zhu HB, Young LJ, Muller WJ, Cardiff RD. CD44v(3,8-10) is involved in cytoskeletal-mediated tumor cell migration and matrix metalloproteinase association in metastatic breast cancer cells. J Cell Physiol 1998, 176:206-215. 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3, 9618160.
31. Bourguignon LY, Zhu H, Shao L, Chen YW. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J Biol Chem 2001, 276:7327-7333. 10.1074/jbc.M006498200, 11084024.
32. Bourguignon LY, Zhu H, Shao L, Chen YW. CD44 interaction with Tiam1 promotes Rac1 signalling and hyaluronic acid-mediated breast tumor cell migration. J Biol Chem 2000, 275:1829-1838. 10.1074/jbc.275.3.1829, 10636882.
33. Sheridan C, Kishimoto H, Fuchs RK, Mehrota S, Bhat-Nakshatri P, Turner CH, Goulet R, Badve S, Nakshatri H. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 2006, 8:R59. 10.1186/bcr1610, 1779499, 17062128.
34. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC. Dynamic interactions of cortactin and membrane type-1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 2006, 66:3034-3043. 10.1158/0008-5472.CAN-05-2177, 16540652.
35. Hotary K, Li XY, Allen E, Stevens SL, Weiss SJ. A cancer cell metalloproteinase triad regulates the basement membrane transmigration program. Genes Dev 2006, 20:2673-2686. 10.1101/gad.1451806, 1578694, 16983145.
36. Littlewood-Evans AJ, Bilbe G, Bowler WB, Farley D, Wlodarksi B, Kokubo T, Inaoka T, Sloane J, Evans DB, Gallagher JA. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res 1997, 57:5386-5390.
37. Udabage L, Brownlee GR, Waltham M, Blick T, Walker EC, Heldin P, Nilsonn SK, Thompson EW, Brown TJ. Antisense mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Cancer Res 2005, 65:6139-6150. 10.1158/0008-5472.CAN-04-1622, 16024615.